93 related articles for article (PubMed ID: 15627062)
1. Immunohistochemical analysis of S6K1 and S6K2 localization in human breast tumors.
Filonenko VV; Tytarenko R; Azatjan SK; Savinska LO; Gaydar YA; Gout IT; Usenko VS; Lyzogubov VV
Exp Oncol; 2004 Dec; 26(4):294-9. PubMed ID: 15627062
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of S6K1 and S6K2 expression in endometrial adenocarcinomas.
Lyzogubov VV; Lytvyn DI; Dudchenko TM; Lubchenko NV; Pogrybniy PV; Nespryadko SV; Vinnitska AB; Usenko VS; Gout IT; Filonenko VV
Exp Oncol; 2004 Dec; 26(4):287-93. PubMed ID: 15627061
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of S6K1 and S6K2 expression in human breast tumors.
Savinska LO; Lyzogubov VV; Usenko VS; Ovcharenko GV; Gorbenko ON; Rodnin MV; Vudmaska MI; Pogribniy PV; Kyyamova RG; Panasyuk GG; Nemazanyy IO; Malets MS; Palchevskyy SS; Gout IT; Filonenko VV
Eksp Onkol; 2004 Mar; 26(1):24-30. PubMed ID: 15112576
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of Ki-67, PCNA and S6K1/2 expression in human breast cancer.
Lyzogubov V; Khozhaenko Y; Usenko V; Antonjuk S; Ovcharenko G; Tikhonkova I; Filonenko V
Exp Oncol; 2005 Jun; 27(2):141-4. PubMed ID: 15995633
[TBL] [Abstract][Full Text] [Related]
5. Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer.
Pérez-Tenorio G; Karlsson E; Waltersson MA; Olsson B; Holmlund B; Nordenskjöld B; Fornander T; Skoog L; Stål O
Breast Cancer Res Treat; 2011 Aug; 128(3):713-23. PubMed ID: 20953835
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
Darmon E; Cleary KR; Wargovich MJ
Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
[TBL] [Abstract][Full Text] [Related]
7. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
8. Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.
Karlsson E; Magić I; Bostner J; Dyrager C; Lysholm F; Hallbeck AL; Stål O; Lundström P
PLoS One; 2015; 10(12):e0145013. PubMed ID: 26698305
[TBL] [Abstract][Full Text] [Related]
9. S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts.
Bostner J; Karlsson E; Eding CB; Perez-Tenorio G; Franzén H; Konstantinell A; Fornander T; Nordenskjöld B; Stål O
Endocr Relat Cancer; 2015 Jun; 22(3):331-43. PubMed ID: 25972244
[TBL] [Abstract][Full Text] [Related]
10. Expression of human telomerase reverse transcriptase gene and protein, and of estrogen and progesterone receptors, in breast tumors: preliminary data from neo-adjuvant chemotherapy.
Kammori M; Izumiyama N; Hashimoto M; Nakamura K; Okano T; Kurabayashi R; Naoki H; Honma N; Ogawa T; Kaminishi M; Takubo K
Int J Oncol; 2005 Nov; 27(5):1257-63. PubMed ID: 16211220
[TBL] [Abstract][Full Text] [Related]
11. Characterization of S6K2, a novel kinase homologous to S6K1.
Lee-Fruman KK; Kuo CJ; Lippincott J; Terada N; Blenis J
Oncogene; 1999 Sep; 18(36):5108-14. PubMed ID: 10490847
[TBL] [Abstract][Full Text] [Related]
12. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study].
Gui K
Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
Cardillo MR; Yap E
J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
[TBL] [Abstract][Full Text] [Related]
14. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):586-93. PubMed ID: 12738950
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of Bin1/Amphiphysin II in human tissues: diverse sites of nuclear expression and losses in prostate cancer.
DuHadaway JB; Lynch FJ; Brisbay S; Bueso-Ramos C; Troncoso P; McDonnell T; Prendergast GC
J Cell Biochem; 2003 Feb; 88(3):635-42. PubMed ID: 12532338
[TBL] [Abstract][Full Text] [Related]
16. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas.
Takenaga K; Nakanishi H; Wada K; Suzuki M; Matsuzaki O; Matsuura A; Endo H
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2309-16. PubMed ID: 9815629
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays.
Mobasheri A; Airley R; Hewitt SM; Marples D
Int J Oncol; 2005 May; 26(5):1149-58. PubMed ID: 15809704
[TBL] [Abstract][Full Text] [Related]
19. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors.
Melhem MF; Meisler AI; Finley GG; Bryce WH; Jones MO; Tribby II; Pipas JM; Koski RA
Cancer Res; 1992 Nov; 52(21):5853-64. PubMed ID: 1394214
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]